Europe Platelet Rich Plasma (Prp) Market Size & Outlook
- Pharmaceuticals
- Blood Disorders Treatment
- Platelet Rich Plasma (PRP) Market Outlook
- Blood Disorders Treatment
Global Report
Related Markets
Ask a question about the platelet rich plasma (prp) market
Europe platelet rich plasma (prp) market highlights
- The Europe platelet rich plasma (prp) market generated a revenue of USD 162.3 million in 2025.
- The market is expected to grow at a CAGR of 14% from 2026 to 2033.
- In terms of segment, pure prp was the largest revenue generating type in 2025.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 162.3 million |
| Market revenue in 2033 | USD 462.8 million |
| Growth rate | 14% (CAGR from 2026 to 2033) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP, Others Type |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.0% of the platelet rich plasma (prp) market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 422.6 million by 2033.
Europe is the second-largest PRP market globally and is anticipated to witness promising growth during the forecast period. This can be attributed to the rising demand for PRP therapy for sports injuries. In addition, expanding applications of PRP therapy, rapid technological advancements, and progressive demographic aging of the older population contribute to the market growth in Europe.
PRP therapy is regulated under Directive 2001/83/EC of the Council of November 6, 2001, and the European Parliament across the EU. This directive is further adapted by each member as per their regulatory framework. In some European countries, PRP products are considered blood derivatives, as the directive has not been translated into national law across Europe.
No credit card required*
Publish Date: Feb 11, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Stryker Corp | View profile | 52,000 | 1941 Stryker Way, Portage, MI, United States, 49002 | www.stryker.com |
| Zimmer Biomet Holdings Inc | View profile | 18,000 | 345 East Main Street, Warsaw, IN, United States, 46580 | www.zimmerbiomet.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Arthrex | View profile | 5001-10000 | Naples, Florida, United States, North America | www.arthrex.com/ |
| EmCyte Corporation | View profile | 11-50 | Fort Myers, Florida, United States, North America | emcyte.com/ |
| Dr. PRP USA | View profile | 11-50 | Stafford, Texas, United States, North America | www.drprpusa.com |
| Juventix Regenerative Medical | View profile | 11-50 | Tampa, Florida, United States, North America | juventix.com/ |
| APEX Biologix | View profile | 11-50 | Murray, Utah, United States, North America | apexbiologix.com |
| Celling Biosciences | View profile | - | - | - |
Europe Platelet Rich Plasma (PRP) Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Platelet Rich Plasma (PRP) Market Outlook will help companies and investors design strategic landscapes.
Pure Prp was the largest segment with a revenue share of 58.16% in 2025.
Horizon Databook has segmented the Europe platelet rich plasma (prp) market based on pure prp, leukocyte rich prp, others type covering the revenue growth of each sub-segment from 2021 to 2033.
Europe is the second-largest PRP market globally and is anticipated to witness promising growth during the forecast period. This can be attributed to the rising demand for PRP therapy for sports injuries. In addition, expanding applications of PRP therapy, rapid technological advancements, and progressive demographic aging of the older population contribute to the market growth in Europe.
PRP therapy is regulated under Directive 2001/83/EC of the Council of November 6, 2001, and the European Parliament across the EU. This directive is further adapted by each member as per their regulatory framework. In some European countries, PRP products are considered blood derivatives, as the directive has not been translated into national law across Europe.
- Europe Platelet Rich Plasma (Prp) Market Type Outlook (Revenue, USD Million , 2021-2033)
- Pure PRP
- Leukocyte Rich PRP
- Others Type
- Europe Platelet Rich Plasma (Prp) Market Application Outlook (Revenue, USD Million , 2021-2033)
- Orthopedics
- Sports Medicine
- Cosmetic Surgery
- Dermatology
- Ophthalmic Surgery
- Neurosurgery
- General Surgery
- Others Application
- Europe Platelet Rich Plasma (Prp) Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Clinics
- Others End Use
Reasons to subscribe to Platelet Rich Plasma (PRP) Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Platelet Rich Plasma (PRP) Market Outlook databook
- Our clientele includes a mix of Platelet Rich Plasma (PRP) Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Platelet Rich Plasma (PRP) Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Platelet Rich Plasma (PRP) Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Platelet Rich Plasma (Prp) Market, 2021-2033 (US$M)
Europe platelet rich plasma (prp) market statistics, by type, 2021-2033 (US$M)
